Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,356
datasets available to search
ShareScore release 0.9.0
Dataset results
10,356 results for “Severity”
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
ClinicalTrials.gov study NCT01597245. IPD Sharing: YES. Countries: 12. Publications: 11.
Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy
ClinicalTrials.gov study NCT02886728. IPD Sharing: NO. Countries: 31. Publications: 8.
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
ClinicalTrials.gov study NCT01580293. IPD Sharing: Not stated. Countries: 20. Publications: 4.
A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age
ClinicalTrials.gov study NCT05650333. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies
ClinicalTrials.gov study NCT00249808. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
ClinicalTrials.gov study NCT00422162. IPD Sharing: Not stated. Countries: 4. Publications: 2.
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT00487539. IPD Sharing: Not stated. Countries: 25. Publications: 3.
A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
ClinicalTrials.gov study NCT03675477. IPD Sharing: NO. Countries: 5. Publications: 1.
Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)
ClinicalTrials.gov study NCT04572997. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01815424. IPD Sharing: YES. Countries: 3. Publications: 1.
Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis
ClinicalTrials.gov study NCT03450083. IPD Sharing: NO. Countries: 1. Publications: 2.
CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat Patients With Severe Aortic Stenosis.
ClinicalTrials.gov study NCT03752866. IPD Sharing: NO. Countries: 9. Publications: 1.
A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03364309. IPD Sharing: YES. Countries: 1. Publications: 2.
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)
ClinicalTrials.gov study NCT00776984. IPD Sharing: Not stated. Countries: 15. Publications: 4.
Drug and Non-Drug Treatment Of Severe Migraine
ClinicalTrials.gov study NCT00910689. IPD Sharing: Not stated. Countries: 1. Publications: 2.
An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT01951170. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD
ClinicalTrials.gov study NCT03256552. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03398148. IPD Sharing: YES. Countries: 44. Publications: 4.
A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis
ClinicalTrials.gov study NCT02387801. IPD Sharing: YES. Countries: 1. Publications: 1.
Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia
ClinicalTrials.gov study NCT04720534. IPD Sharing: Not stated. Countries: 8. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.